Lyell Immunopharma, Inc. (LYEL)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 57
-2.32
-15.5809%
$
390.38M Market Cap
- P/E Ratio
- Div Yield
412,847 Volume
-0.85 Eps
$ 14.89
Previous Close 
Want to track LYEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3 Biotech Stocks to Sell in August Before They Crash & Burn
For investors, one of the most attractive aspects of biotech stocks is their ability to increase in value in a short period of time quickly. After all, it only takes one major breakthrough in clinical trials or a Food and Drug Administration approval to rush a stock into the headlines rapidly.
Investorplace | 1 year ago
